Zusammenfassung
Seit einigen Jahren häufen sieh die Hinweise, dass zwischen Kindern mit ADS/ADHS und gesunden Kindern vielfältige neurobiologische Unterschiede bestehen. Demnach ist ADS/ADHS nicht nur mit genetischen Veränderungen, sondern auch mit strukturellen und funktionellen Gehirnanomalien und neuropsychologischen Auffälligkeiten assoziiert.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Literatur
Alexander GE et al. (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9: 357–81
Zametkin AJ, Rapoport JL (1987) Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 26 (5): 676–86
Faraone SV et al. (2000) Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet Epidemio 18 (1): 1–16
Swanson JM et al. (2000) Dopamine genes and ADHD. Neurosci Biobehav Rev 24 (1): 21–5
Curran S et al. (2001) Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 6 (4): 425–8
Moll G, Rothenberger A (2000) in Förstl (Hrsg), Klinische Neuro-Psychiatrie, 150–90; Thieme, Stuttgart
Rubia K et al. (2001) Neuropsychological analyses of impulsiveness in childhood hyperactivity. Br J Psychiatry 179:138–43
Sieg KG et al. (1995) SPECT brain imaging abnormalities in attention deficit hyperactivity disorder. Clin Nucl Med 20(1): 55–60
Banaschewski T, Rothenberger A (2001) Berner Schriftenreihe 3: 47–67
Rubia K et al. (1999) Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRl. Am J Psychiatry 156 (6): 891–6
Rothenberger A, Schmidt MH (2000) Die Funktion des Frontalhirns und der Verlauf psychischer Störungen. Lang, Frankfurt
Bush G et al. (1999) Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRl and the Counting Stroop. Biol Psychiatry 45 (12): 1542–52
Moll GH et al. (2000) Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Letters 284: 121–5
Kuperman S et al. (1990) Neuroimaging in child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry 29 (2): 159–72
Michelson D et al. (2002) Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159: 1896–901
Avery RA et al. (2000) The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharma- col 23 (3): 420–9
Manor I et al. (2001) Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am J Med Genet 105 (1): 91–5
Himelstein J et al. (2000) The neurobiology of attention-deficit hyperactivity disorder. Front Biosci 5: D461–78
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg New York
About this paper
Cite this paper
Rothenberger, A., Banaschewski, T., Uebel, H. (2003). Neurobiologische Grundlagen eines pathophysiologischen Erklärungsmodells. In: Schulte-Markwort, M., Zinke, M. (eds) ADS/ADHS Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-92473-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-92473-6_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00140-9
Online ISBN: 978-3-642-92473-6
eBook Packages: Springer Book Archive